Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_assertion type Assertion NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_head.
- NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_assertion description "[This study analyzes the relationship between risk factors related to overweight/obesity, insulin resistance, lipid tolerance, hypertension, endothelial function and genetic polymorphisms associated with: i) appetite regulation (leptin, melanocortin-3-receptor (MCR-3), dopamine receptor 2 (D2R)); ii) adipocyte differentiation and insulin sensitivity (peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2), tumor necrosis factor-alpha (TNF-alpha)); iii) thermogenesis and free fatty acid (FFA) transport/catabolism (uncoupling protein-1 (UCP1), lipoprotein lipase (LPL), beta2- and beta3-adrenergic receptor (beta2AR, beta3AR), fatty acid transport protein-1 (FATP-1) and iv) lipoproteins (apoliprotein E (apoE), apo CIII).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_provenance.
- NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_assertion evidence source_evidence_literature NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_provenance.
- NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_assertion SIO_000772 15202783 NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_provenance.
- NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_assertion wasDerivedFrom befree-2016 NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_provenance.
- NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_assertion wasGeneratedBy ECO_0000203 NP448612.RALfgIbukwyvUu3douD2CSU-MvG0wUb4J9FSG3wRBGw7s130_provenance.